They discovered that PGE2 activates renal Sox9+ cells, driving their differentiation into proximal tubular epithelial cells while inhibiting fibrosis, underscoring PGE2’s potential for AKI regenerative therapy.87 This evidence concerns the gene SOX9 and acute kidney injury.